Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Erythropoietin Dosing in Preterm Infants
NCT01235923Phase 2Completed
- Sponsor
- The University of New Mexico
- Start
- Apr 2006
- Primary completion
- Mar 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in anemia of prematurity (AOP), sponsored by The University of New Mexico. Started Apr 2006; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia of prematurity (AOP)
Beyond the preview
Go deeper on NCT01235923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235923.